This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Should You Hold Onto Eastman Chemical Stock for Now?
by Anindya Barman
Eastman Chemical (EMN) is gaining from growth of its high-margin specialty products and cost management actions.
Eastman Chemical (EMN) to Bump Up Prices of Amines Products
by Zacks Equity Research
Eastman Chemical (EMN) is raising selling prices of products in the wake of raw material price inflation.
Eastman Chemical (EMN) Hikes Prices of Choline Chloride
by Zacks Equity Research
Eastman Chemical (EMN) is raising prices of these products in the wake of higher operating costs.
Eastman Chemical (EMN) and Clariant Ink Agrochemical Deal
by Zacks Equity Research
Eastman Chemical's (EMN) agrochemical collaboration deal with Clariant to enable the distribution of Tamisolve NxG solvent for the agrochemical industry.
Eastman Chemical (EMN) Raises Global Cellulosic Yarn Prices
by Zacks Equity Research
Eastman Chemical (EMN) takes actions to raise selling prices of products in the wake of raw material price inflation.
Eastman Chemical's (EMN) Board Announces 11% Hike in Dividend
by Zacks Equity Research
Eastman Chemical (EMN) is committed towards balanced and disciplined capital allocation and shareholders returns.
Eastman Chemical (EMN) Completes Acid Manufacturing Facility
by Zacks Equity Research
Eastman Chemical (EMN) is committed to provide consistent isobutyric acid supply to customers globally and meet market demand for the product.
Is Eastman Chemical (EMN) a Great Stock for Value Investors?
by Zacks Equity Research
Is Eastman Chemical (EMN) a great pick from the value investor's perspective right now? Read on to know more.
Eastman Chemical (EMN) Poised on Cost Actions & Acquisitions
by Anindya Barman
Eastman Chemical (EMN) should gain from its cost management actions and synergies of acquisitions amid headwinds from higher raw material prices.
Eastman Chemical Completes IATF Transition at Saflex Sites
by Zacks Equity Research
The completion of IATF certification shows Eastman Chemical's (EMN) commitment to its customers supplying to the automotive industry.
Eastman Chemical (EMN) Set to Increase Prices of Esters
by Zacks Equity Research
Eastman Chemical (EMN) increases off-list prices of Esters in North and Latin America.
Eastman Chemical (EMN) Announces Start of MDIPA Unit in China
by Zacks Equity Research
Eastman Chemical's (EMN) move reflects commitment to customers as well as ability to execute projects safely and timely. It is expanding its alkyl alkanolamine capacity in Nanjing.
Near-Term Prospects Cloudy for Diversified Chemical Stocks
by Zacks Equity Research
Diversified chemical companies are hamstrung by raw material cost pressure and ongoing trade tensions between Washington and Beijing.
Eastman Chemical (EMN) Q3 Earnings, Revenues Top Estimates
by Anindya Barman
Eastman Chemical's (EMN) Q3 results surpassed expectations and the company reaffirmed its earnings growth outlook for 2018.
Eastman Chemical (EMN) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Eastman Chemical (EMN) delivered earnings and revenue surprises of 2.18% and 0.48%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Chemical Stock Earnings Slated for Oct 25: PX, EMN & AXTA
by Zacks Equity Research
Investors should check these chemical stocks before their quarterly results as the industry is expected to sustain the momentum in Q3.
Can Eastman Chemical (EMN) Sustain Earnings Streak in Q3?
by Anindya Barman
Eastman Chemical's (EMN) high margin products and productivity actions are likely to support its Q3 earnings.
LyondellBasell's PP Copolymer Advances Medicine Storage
by Zacks Equity Research
LyondellBasell's (LYB) Purell EP374M product maintains toughness and impact resistance within a broad temperature window.
Eastman Chemical (EMN) Q3 Earnings Preview: How Are Events Shaping Up?
by Zacks Equity Research
Eastman Chemical (EMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Celanese to Raise Prices of Ateva EVA & VAE Emulsion Polymers
by Zacks Equity Research
Celanese (CE) takes appropriate pricing actions amid a volatile pricing environment for raw materials.
5 Reasons to Add Eastman Chemical (EMN) to Your Portfolio
by Anindya Barman
Based on its compelling prospects, we believe Eastman Chemical (EMN) has plenty of upside potential.
Eastman Chemical Hikes DMAPA Prices Amid High Operating Costs
by Zacks Equity Research
Eastman Chemical's (EMN) latest pricing action is in response to elevated operation costs, especially of raw materials.
Eastman Chemical (EMN) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eastman Chemical (EMN) have what it takes? Let's find out.
Celanese (CE) Poised to Gain on Productivity & Growth Actions
by Anindya Barman
Celanese's (CE) productivity actions and growth initiatives, including acquisitions, are likely to lend support to its earnings in 2018.
Eastman Chemical to be Aided by Acquisitions & Cost Reduction
by Zacks Equity Research
Eastman Chemical's (EMN) strategic acquisitions and cost-cutting actions are likely to drive growth, amid headwinds from raw-material cost inflation.